DexCom, Inc. (LON:0A4M)

Market Cap	25.24B
Revenue (ttm)	3.21B
Net Income (ttm)	414.24M
Shares Out	n/a
EPS (ttm)	1.03
PE Ratio	60.94
Forward PE	38.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38
Average Volume	2,647
Open	70.74
Previous Close	n/a
Day's Range	70.74 - 70.74
52-Week Range	49.56 - 112.76
Beta	n/a
RSI	36.00
Earnings Date	Apr 24, 2025

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A4M

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD